English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/44797
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Molecular characterization of the safracin biosynthetic pathway from Pseudomonas fluorescens A2-S: designing new antitumor compounds

AuthorsVelasco, Ana; Acebo País, Paloma; Gómez, Alicia; Schleissner, Carmen; Rodríguez, Pilar; Aparicio Pérez, Tomás; Conde, Susana; Muñoz, Rosario CSIC ORCID ; Calle, Fernando de la; García, José Luis CSIC ORCID ; Sánchez-Puelles, José María CSIC ORCID
Keywordssynthesis of safracin
Safracin biosynthetic pathway
Bacterial strains
Issue DateApr-2005
PublisherWiley-Blackwell
CitationMolecular Microbiology 56(1): 144–154 (2005)
AbstractSafracin is an antibiotic with anti-tumour activity produced by Pseudomonas fluorescens A2-2. The entire safracin synthetic gene cluster spanning 17.5 kb has been identified, cloned and sequenced. The safracin cluster comprises 10 open reading frames (ORFs) encoding proteins for three non-ribosomal peptide synthetases (NRPS), three safracin precursor biosynthetic enzymes, two safracin tailoring enzymes, a safracin resistance protein and a small hypothetical protein of unknown function. These genes are organized in two divergent operons of eight and two genes respectively. This pathway exhibits unusual features when compared with other NRPS systems. We have demonstrated by heterologous expression of the cluster that it is able to direct the synthesis of safracin in other strains. Cross-feeding experiments have confirmed that 3-hydroxy-5-methyl- O -methyltyrosine is the precursor of two amino acids of the molecule. Genetic analyses have allowed us to demonstrate that the bicistronic operon encodes the hydroxylation and N-methylation activities of the pathway. The cloning and expression of the safracin cluster has settled the basis for the in vivo and in vitro production of a wide
Publisher version (URL)http://dx.doi.org/10.1111/j.1365-2958.2004.04433.x
URIhttp://hdl.handle.net/10261/44797
DOIhttp://dx.doi.org/10.1111/j.1365-2958.2004.04433.x
ISSN0950-382X
E-ISSN1365-2958
Appears in Collections:(CIB) Artículos
(IFI) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.